Testing LV232 capsules for major depression
Treatments studied
Part of Mental health clinical trials.
This trial tests a new medicine called LV232 for people with moderate to severe depression. Researchers want to find the best dose and check if it works safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You have been diagnosed with depression and currently have at least a moderate episode (MADRS score 26 or higher).
- If this is your first episode, it has lasted 3 months or more; if recurrent, at least 1 month.
- You have not tried two different antidepressants for at least 8 weeks without success (treatment-resistant depression).
- You do not have other major mental health conditions like bipolar disorder, schizophrenia, or severe anxiety.
- You agree to use effective contraception if needed, from now until 3 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called LY03021 in healthy volunteers to see how safe it is, how the body processes it, and if food changes its effects. It's for people who are generally healthy and not taking other medications.
This study tests a new antidepressant tablet against an approved one to see which works better and is safer for adults with major depression. It may help find a more effective option for treating depressive symptoms.
This trial tests an experimental film placed inside the cheek (VLS-01) against a placebo to see if it helps people whose depression hasn't improved with standard antidepressants. If you have tried at least two antidepressants without success, this study may be an option for you.
This trial tests an investigational drug called LB-102 for people with bipolar I disorder who are currently experiencing a major depressive episode without psychosis. It aims to see if the drug is safe and effective for treating depression symptoms.
This study tests an investigational drug called KH607 for adults with major depressive disorder (MDD). It aims to see if the drug can reduce depression symptoms over time. Participants must stop other depression medications before starting and will be monitored closely.
This study tests a new medicine called ammoxetine for people with major depression. It aims to see if it can help reduce depressive symptoms.
Hear when a new MDD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.